BIOMAT Database Logo BIOMAT Database Logo

Elevated tricyclic antidepressant plasma concentrations associated with fluoxetine: two case reports. 1990

M Michals, and D A Stanley, and M L Crismon, and N E Barrow

UI MeSH Term Description Entries
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D009661 Nortriptyline A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions. Desitriptyline,Desmethylamitriptylin,Allegron,Apo-Nortriptyline,Aventyl,Gen-Nortriptyline,Norfenazin,Nortrilen,Nortriptyline Hydrochloride,Novo-Nortriptyline,Nu-Nortriptyline,PMS-Nortriptyline,Pamelor,Paxtibi,ratio-Nortriptyline,Apo Nortriptyline,Gen Nortriptyline,Hydrochloride, Nortriptyline,Novo Nortriptyline,Nu Nortriptyline,PMS Nortriptyline,ratio Nortriptyline
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D003891 Desipramine A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors. Desmethylimipramine,Apo-Desipramine,Demethylimipramine,Desipramine Hydrochloride,Norpramin,Novo-Desipramine,Nu-Desipramine,PMS-Desipramine,Pertofran,Pertofrane,Pertrofran,Petylyl,Ratio-Desipramine,Apo Desipramine,Hydrochloride, Desipramine,Novo Desipramine,Nu Desipramine,PMS Desipramine,Ratio Desipramine
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005473 Fluoxetine The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants. Fluoxetin,Fluoxetine Hydrochloride,Lilly-110140,N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine,Prozac,Sarafem,Lilly 110140,Lilly110140
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Michals, and D A Stanley, and M L Crismon, and N E Barrow
Increased plasma tricyclic antidepressant concentrations in two patients concurrently treated with fluoxetine.
June 1989, The Journal of clinical psychiatry,
M Michals, and D A Stanley, and M L Crismon, and N E Barrow
Evaluation of risk factors for elevated tricyclic antidepressant plasma concentrations.
March 2009, Pharmacoepidemiology and drug safety,
M Michals, and D A Stanley, and M L Crismon, and N E Barrow
Tricyclic antidepressant plasma levels after fluoxetine addition.
January 1992, Neuropsychobiology,
M Michals, and D A Stanley, and M L Crismon, and N E Barrow
Monitoring tricyclic antidepressant plasma concentrations.
June 1979, JAMA,
M Michals, and D A Stanley, and M L Crismon, and N E Barrow
Fluoxetine and elevated plasma levels of tricyclic antidepressants.
September 1990, The American journal of psychiatry,
M Michals, and D A Stanley, and M L Crismon, and N E Barrow
The prediction of tricyclic antidepressant plasma concentrations.
January 1980, Postgraduate medical journal,
M Michals, and D A Stanley, and M L Crismon, and N E Barrow
Elevated antidepressant plasma levels after addition of fluoxetine.
July 1989, The American journal of psychiatry,
M Michals, and D A Stanley, and M L Crismon, and N E Barrow
Long-term monitoring of tricyclic antidepressant plasma concentrations.
November 1980, The British journal of psychiatry : the journal of mental science,
M Michals, and D A Stanley, and M L Crismon, and N E Barrow
Serotonin Syndrome With Fluoxetine: Two Case Reports.
January 2016, Ochsner journal,
M Michals, and D A Stanley, and M L Crismon, and N E Barrow
Intrapatient variability of serial steady-state plasma tricyclic antidepressant concentrations.
April 1978, Journal of pharmaceutical sciences,
Copied contents to your clipboard!